<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang W</submitter><funding>Nanjing Medical University Fan Daiming Research Funds for Holistic Integrative Medicine</funding><funding>National Key Research and Development Program of China</funding><pagination>289-301</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12911655</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Current microbiome-based therapeutics face two prominent issues: the limited clinical efficacy of probiotics and the significant variability in the efficacy of microbiota transplantation across different diseases. Although washed microbiota transplantation (WMT) is a new faecal microbiota transplantation, a single therapeutic agent cannot be universally effective for multiple dysbiosis-related diseases.&lt;h4>Objective&lt;/h4>We introduced a new therapeutic concept, X-augmented WMT (X-auWMT), which combines a disease-specific beneficial microbe, 'X', with WMT to enhance its effectiveness. Our goal was to identify a candidate 'X' bacterium to augment WMT efficacy and examine the efficacy of X-auWMT in animal models of radiation enteritis (RE).&lt;h4>Design&lt;/h4>We conducted a prosp</pubmed_abstract><journal>Gut</journal><pubmed_title>&amp;lt;i&amp;gt;Holdemanella biformis&amp;lt;/i&amp;gt; augments washed microbiota transplantation for the treatment of radiation enteritis.</pubmed_title><pmcid>PMC12911655</pmcid><funding_grant_id>2023-3HIM</funding_grant_id><funding_grant_id>2021YFA0717004</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Lu C</pubmed_authors><pubmed_authors>Wen Q</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Liang C</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Lu G</pubmed_authors><pubmed_authors>Wang R</pubmed_authors><pubmed_authors>Yi B</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Bai J</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors><pubmed_authors>Cui B</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;i&amp;gt;Holdemanella biformis&amp;lt;/i&amp;gt; augments washed microbiota transplantation for the treatment of radiation enteritis.</name><description>&lt;h4>Background&lt;/h4>Current microbiome-based therapeutics face two prominent issues: the limited clinical efficacy of probiotics and the significant variability in the efficacy of microbiota transplantation across different diseases. Although washed microbiota transplantation (WMT) is a new faecal microbiota transplantation, a single therapeutic agent cannot be universally effective for multiple dysbiosis-related diseases.&lt;h4>Objective&lt;/h4>We introduced a new therapeutic concept, X-augmented WMT (X-auWMT), which combines a disease-specific beneficial microbe, 'X', with WMT to enhance its effectiveness. Our goal was to identify a candidate 'X' bacterium to augment WMT efficacy and examine the efficacy of X-auWMT in animal models of radiation enteritis (RE).&lt;h4>Design&lt;/h4>We conducted a prosp</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T07:11:47.242Z</modification><creation>2026-07-09T10:43:13.497Z</creation></dates><accession>S-EPMC12911655</accession><cross_references><pubmed>40947138</pubmed><doi>10.1136/gutjnl-2025-335230</doi></cross_references></HashMap>